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The nuclear receptor superfamily comprises ligand-regulated transcription factors that control various
developmental and physiological pathways.These receptors share a common modular structure and regulate
gene expression through the recruitment of a large set of coregulatory proteins.These transcription cofactors
regulate, either positively or negatively, chromatin structure and transcription initiation. One of the first
proteins to be identified as a hormone-recruited cofactor was RIP140. Despite its recruitment by
agonist-liganded receptors, RIP140 exhibits a strong transcriptional repressive activity which involves several
inhibitory domains and different effectors. Interestingly, the RIP140 gene, located on chromosome 21 in
humans, is finely regulated at the transcriptional level by various nuclear receptors. In addition, the protein
undergoes several post-translational modifications which control its repressive activity. Finally, experiments
performed in mice devoid of the RIP140 gene indicate that this transcriptional cofactor is essential for female
fertility and energy homeostasis. RIP140 therefore appears to be an important modulator of nuclear receptor
activity which could play major roles in physiological processes and hormone-dependent diseases.
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History
In the early 90’s, one of the main goals for several
laboratories working on nuclear receptor (NR) signaling
was to identify associated proteins which could act as
transcriptional coregulators.The efforts were initially
focused on partners of the ligand binding domain (LBD)
encompassing the ligand-dependent activating function
(AF-2) because it was the most convenient (due to the
existence of inactivating mutations and to the use of
antagonist ligands).
RIP140 (Receptor Interacting Protein of 140 kDa) was
one of the first NR transcriptional cofactors to be isolated.
It was first identified by far-western blotting in human
cancer cell extracts using a chimeric radiolabeled probe
containing the ligand binding domain (LBD) of the mouse
ERα fused to the glutathione-S-transferase [Cavailles et
al., 1995]. In the presence of estradiol, this probe detected
several bands corresponding to RIP140 and to the p160
family of coactivators. Using the same strategy, the
RIP140 cDNA was then isolated from a cDNA expression
library established from ZR75-1 breast cancer cells
[Cavailles et al., 1995].
The mouse RIP140 cDNA was isolated 3 years later from
a mouse embryonic library using a yeast two hybrid
strategy using the LBD of the orphan TR2 receptor as a
bait [Lee et al., 1998]. Currently, the cDNA sequences
from several species including rat, dog, chicken, xenopus
and zebra fish have been deposited in databases.The
RIP140 gene is also known as NRIP1 (Nuclear
Receptor-Interacting Protein 1) which is the official symbol
provided by the HUGO gene nomenclature committee.
Protein domain structure
The human RIP140 protein comprises 1158 amino acids
with an overall important identity between species (83%
of amino acid identity between human and mouse
sequences).When the RIP140 cDNA was isolated, no
known conserved motifs were found in the deduced
primary sequence by comparison to databases. However,
several important functional domains allowing interaction
with different partners (i.e., nuclear receptors and
downstream effectors) have now been identified (see the
sections on Interactions with nuclear receptors, Role in
Transcription Control, and Post-translational modifications
and Figure 1). In addition, and as expected for a
transcriptional regulator, the RIP140 protein contains two
putative nuclear localization signals (NLS) located at
position 97 (KRKR monopartite NLS) and 856
(KKRKx10KKMK bipartite motif).
Interactions with nuclear receptors
Identification of interacting motifs
Since its isolation as an ERα partner, RIP140 was shown
to interact with many other nuclear receptors (NRs) such
as RARα/β, RXRα/β, TRα/β [L'Horset et al., 1996;Treuter
et al., 1998], GR [Subramaniam et al., 1999;Windahl et
al., 1999], AR [Bevan et al., 1999; Carascossa et al.,
2006; Ikonen et al., 1997], VDR [Masuyama et al., 1997],
PPARα/γ/δ [Lim et al., 2004;Treuter et al., 1998;Windahl
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Review  Nuclear Receptor Signaling  |  The Open Access Journal of the Nuclear Receptor Signaling AtlasFigure 1. Schematic representation of RIP140 structure. The boxes represent the RIP140 molecule showing respectively the different functional
domains together with post-translational modifications and single nucleotide polymorphisms.The numbers correspond to the amino acid position on
the molecule. A) Repression domains (RD).The four domains (RD1 to 4) map respectively to the regions located between residues 27 and 199 429
and 700, 753 to 804 and 1118 to 1158 (Castet et al. 2004; Christian et al. 2004;Vo et al. 2001;Wei et al. 2000;Wei et al. 2001). B) Interacting motifs.
The ten LxxLL NR binding sites (Heery et al. 1997) and the atypical LxxML motif (Chen et al. 2002) are shown together with the two putative nuclear
localization signals at position 97 and 856, the 14-3-3 binding motif (RTFSYP) (Zilliacus et al. 2001) and the CtBP binding sites PIDLS and PINLS at
position 440 and 565 (Castet et al. 2004; Christian et al. 2004;Vo et al. 2001). C) Post-translational modifications.The figure shows phosphorylation
(S104, S358, S380, S488, S519, S531, S543, S672, S1003, T202 and T207) (Huq et al. 2005a; Gupta et al. 2005) and acetylation sites (K111, K118,
K287, K211, K446, K482, K529, K607, K932) (Huq and Wei 2005b;Vo et al. 2001). D) Single nucleotide polymorphism (SNPs).The six SNPs causing
amino acid sequence changes in the human RIP140 protein correspond to G75G, H221R, Y315F, I441V, R448G, S803L (Caballero et al. 2005).
et al., 1999], LXRα [Miyata et al., 1998], PXR [Masuyama
et al., 2001], LXRβ, HNF4α and RORβ [Albers et al.,
2005], ERRα/β/γ [Castet et al., 2006; Sanyal et al., 2004],
SF1 and DAX-1 [Sugawara et al., 2001], TAK1/TR4 [Yan
et al., 1998] and TR2 [Lee et al., 1998].
As shown in Figure 1, the RIP140 protein contains nine
NR interacting boxes (LxxLL motifs) spread throughout
the molecule [Heery et al., 1997]. Interestingly, the binding
of RIP140 to RAR and RXR requires a slightly divergent
sequence corresponding to an LxxML motif and located
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The binding of RIP140 to NRs primarily requires an active
AF-2 domain since it is disrupted by mutations in the helix
12 [Cavailles et al., 1994].The RIP140 binding site
overlaps that of coactivators such as members of the
SRC family (p160 proteins) [Eng et al., 1998], thus
explaining why the two types of molecules compete for
interaction with NRs [Eng et al., 1998;Treuter et al.,
1998].The various LxxLL motifs present in the RIP140
sequence display distinct preferences for nuclear
receptors.In vitro interaction assays showed that liganded
TRβ has a clear preference for RIP140 LxxLL motifs 3,
5 and 8 [Moore et al., 2004]. Moreover, when evaluated
in yeast [Heery et al., 2001] or mammalian [Hu and
Funder, 2006] two-hybrid assays, the nine LxxLL motifs
exhibited different relative affinities for steroid or retinoid
receptors, the central LxxLL motif 6 (residues 500 to 504)
being the most efficient in interacting with GR, ERα and
RARα.
RIP140 also interacts with other transcription factors like
c-jun [Teyssier et al., 2003] or the aryl hydrocarbon
receptor (AhR) [Kumar et al., 1999].The interaction with
AhR occurs independently of NR boxes through a domain
that was mapped between amino acid residues 154 and
350 [Kumar et al., 1999].
Recruitment of RIP140 on target genes
During the past five years, chromatin immunoprecipitation
(ChIP) assays have been used to confirm the interaction
of transcription factors on their target genes and to
describe the cyclical recruitment of the transcription
machinery [Metivier et al., 2006]. However, in the case
of RIP140, very few kinetics studies using ChIP assays
were reported. In RA-treated P19 cells, RIP140 was
detected in a cyclic fashion on RAR-targeted genes such
as the RARβ2 and TR2 promoters [Chen et al., 2004; Hu
et al., 2004]. Interestingly, these studies presented kinetic
evidence for competition of RIP140 with P/CAF for
ligand-dependent interactions with RAR/RXR on targeted
promoters. Later on, other studies demonstrated the
ligand-dependent recruitment of RIP140 on target genes.
This was described on the RARα promoter in the
presence of E2 [Laganiere et al., 2005] and on the PSA
(prostate specific antigen) enhancer and promoter upon
treatment of LNCaP cells with R1881 [Carascossa et al.,
2006].
Role in transcription control
Repression of transcription
RIP140 appears to be an unconventional NR coregulator.
Indeed, despite its recruitment by agonist-liganded
receptors, which initially suggested that it might act as a
transcriptional coactivator, most of the published data
indicates that RIP140 inhibits target gene transcription.
It was initially proposed that this transcriptional repression
occurred by competition with coactivators [Treuter et al.,
1998]. Indeed, evidence was provided that the in vitro
binding of RIP140 and SRC-1 to nuclear receptors was
competitive and might account for the negative effect of
RIP140 on hormone-dependent transcription.
More recently, it was demonstrated that RIP140 displayed
active repression. Experiments using the full-length
RIP140 sequence tethered to the GAL4-DBD revealed a
transrepressive activity on the reporter gene [Lee et al.,
1998].When global analysis of the transcriptome was
compared in wild-type and RIP140-null cells, a significant
proportion of genes were found to be increased in cells
which did not express RIP140 [Christian et al., 2005],
thus confirming a direct or indirect RIP140-associated
repression of transcription.
Four repressive domains (RD) have been identified in the
RIP140 molecule ([Castet et al., 2004; Christian et al.,
2004] and Figure 1).The RD1 encompasses a region
located between residues 27 and 199 which acts by
recruiting class I and II histone deacetylases (HDACs)
[Castet et al., 2004;Wei et al., 2001;Wei et al., 2000].
The RD2 maps to the region located between amino acids
429 and 739 and interacts with carboxyl-terminal-binding
proteins (CtBP1 and CtBP2) through two conserved motifs
(sequences PIDLS and PINLS) [Castet et al., 2004;Vo
et al., 2001].The RD3 and RD4 are located in the
carboxyl-terminal region of the molecule and correspond
respectively to amino acid residues 753-804 and
1118-1158, but no downstream effectors have yet been
identified.
Very interestingly, several post-translational modifications
seem to play an important role in controlling the
repressive activity of RIP140 (see the section on
Post-translational modifications below and Figure 1).
Activation of transcription
Although RIP140 mainly exerts a negative effect on
transcription, several reports have described positive
effects on gene expression.The most convincing situation
concerns the effect in yeast where transactivation was
reproducibly observed on different nuclear receptors such
as ERα [Nephew et al., 1998; Sheeler et al., 2000], RARα
[Joyeux et al., 1997] or GR [Windahl et al., 1999].
In mammalian cells, activation of transcription has also
been linked to RIP140 overexpression. In transient
transfection experiments, low concentrations of RIP140
expression plasmid led to a slight but significant increase
in ERα [Cavailles et al., 1995; Henttu et al., 1997] or AhR
activity [Kumar et al., 1999]. More recently, RIP140 was
reported to strongly stimulate transactivation by ERRα
and ERRγ when they regulated transcription of target
genes through Sp1 sites [Castet et al., 2006].This
regulation could be due to an indirect effect of RIP140
overexpression which might titrate away from the
promoter (a) transcriptional repressor(s) of Sp1 activity.
Based on their ability to interact with both Sp1 and
RIP140, HDACs appear to be good candidates to mediate
such an indirect regulation.
In addition, RIP140 overexpression is also associated
with an increase in transcription when activated nuclear
receptors repress gene expression. For instance, RIP140
relieved the negative effect of glucocorticoids on nGRE
or NFk-B sites [Subramaniam et al., 1999] or the
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1999].
Post-translational modifications of the
RIP140 protein
Phosphorylation
Phosphorylation of RIP140 was first suggested by
experiments showing that its interaction with 14-3-3 was
decreased upon treatment with alkaline phosphatase
[Zilliacus et al., 2001]. 14-3-3 proteins form a family of
highly conserved ubiquitous factors which act as
regulators of a wide range of biological processes [Darling
et al., 2005].They interact directly with a large number
of target proteins and alter their activity, localization or
protein-protein interactions (see below). Recently, the
mapping of phosphorylation sites was achieved by liquid
chromatography-tandem mass spectroscopy [Huq et al.,
2005]. Phosphorylation, which occurs on nine serines
and two threonine residues (Figure 1), participates in the
regulation of RIP140 biological activity. Experiments using
either mutagenesis of the phosphorylated residues or
kinase activators or inhibitors suggest that
MAPK-phosphorylation of Thr202 and 207 increases the
transrepressive activity of RIP140 in part by regulating
its interaction with HDAC3 [Gupta et al., 2005].
Acetylation
RIP140 is also modified by acetylation as shown by initial
studies demonstrating the acetylation of human RIP140
by CBP [Vo et al., 2001]. In this study, the major (but not
the sole acetylation site) was found to be lysine 446.
Acetylation of RIP140 inhibits its interaction with CtBP1
and is associated with a lower transrepressive activity.
More recently, a proteomic analysis of the acetylation
pattern of RIP140 revealed eight acetylated lysines in the
amino-terminal and central region of the protein
expressed in insect cells (Figure 1) [Huq and Wei, 2005].
Paradoxically, in this study, the use of an HDAC inhibitor
increased the repressive activity of RIP140, as previously
reported by others [Castet et al., 2004].This apparent
discrepancy concerning the contribution of HDAC
enzymatic activity to the transcriptional repression exerted
by RIP140 might reflect cell specific effects with, for
instance, a different requirement for HDACs and/or CtBPs
to inhibit transcription according to the cell type.
Subcellular localization
By indirect fluorescence using a rabbit antiserum raised
against a synthetic peptide, the RIP140 protein was
localized in nuclear dots and appeared excluded from
nucleoli [Cavailles et al., 1995].This was supported by
data obtained using a fluorescent tagged version of the
mouse [Lee et al., 1998] or human [Carascossa et al.,
2006; Zilliacus et al., 2001] protein showing an
intranuclear distribution in foci which appeared to be
different from PML bodies [Tazawa et al., 2003]. By
mutagenesis, the domain of human RIP140 responsible
for its targeting to small nuclear dots was mapped to
amino acids 431 to 472 [Tazawa et al., 2003].
The subcellular localization seems to be regulated by
different mechanisms. In hyperacetylation conditions
(treatment with an HDAC inhibitor) the mouse RIP140
protein, expressed as a GFP fusion protein, appears
slightly delocalized into the cytoplasm [Huq and Wei,
2005]. A similar partial relocalization to the cytoplasmic
compartment was induced by the 14-3-3 protein which
directly interacts with RIP140 through a consensus 14-3-3
binding site (RTFSYP) [Zilliacus et al., 2001]. In addition,
upon overexpression of 14-3-3 protein, the nuclear signal
was also relocalized from punctuate to a diffuse pattern.
Interestingly, the same effect was reported upon activation
of glucocorticoid [Tazawa et al., 2003] or androgen
[Carascossa et al., 2006] receptors.The exact role of this
intranuclear redistribution of RIP140 remains to be
defined. One hypothesis could be that the foci represent
a compartment dedicated to the storage of a repressive
machinery including RIP140.
Structure and expression of the gene
The human RIP140 gene was initially mapped to
chromosome 21 in the region q11.2 by fluorescence in
situ hybridization [Cavailles et al., 1995].This was
confirmed using artificial chromosomes, showing that the
gene maps to a gene-poor region of the genome [Katsanis
et al., 1998]. Interestingly, all the RIP140 coding sequence
is comprised in a single large exon and it was believed
that the gene was intron-less. However, several short
non-coding exons (which undergo alternative splicing)
have been recently identified in the 5’ region of the gene
and the promoter mapped about 100kb upstream of the
ATG [Augereau et al., 2006]. RIP140 is a ubiquitously
expressed gene.The mRNA was detected in a very large
number of human cell lines [Cavailles et al., 1995]. In the
mouse, the mRNA was detected in all the tested tissues
with a strong expression in the testis and in the brain [Lee
et al., 1998].The accumulation of the RIP140 mRNA is
increased by different stimuli (Table 1). In human breast
cancer cells, RIP140 mRNA levels are up-regulated by
estrogens, retinoids and dioxin [Augereau et al., 2006;
Cavailles et al., 1994; Kerley et al., 2001]. In prostate
cancer cells, the mRNA steady-state levels are increased
by androgens [Carascossa et al., 2006]. More recently,
RIP140 expression was shown to be stimulated by ERRα
during mouse adipogenesis [Nichol et al., 2006].
The regulation by estrogens is direct (i.e., it does not
require synthesis of an intermediary protein as judged by
the absence of effect of cycloheximide) [Thenot et al.,
1999] and operates at the transcriptional level [Augereau
et al., 2006].Transcriptional profilings of ER-regulated
genes using stably transfected U2OS cells expressing
either ERα or ERβ have also identified RIP140 as an
E2-regulated gene although the relative induction by the
two isoforms of ER varied according to the study [Monroe
et al., 2003; Stossi et al., 2004].
A consensus ERE (which binds the ERα in gel shift and
ChIP experiments) has been mapped in the 5’ proximal
region of the gene [Augereau et al., 2006; Bourdeau et
al., 2004; Lin et al., 2004]. However, it has been proposed
that FoxA1 sites might function as a distal enhancer
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it was observed together with the magnitude of the regulation (fold induction).When indicated, the underlying mechanism (direct or indirect effect at
the transcriptional level) is also mentioned.
facilitating the recruitment of ERα on the RIP140 promoter
[Carroll et al., 2005]. Interestingly, this ERE overlaps with
the response element for AhR and transcriptional
interference occurs between the two activities [Augereau
et al., 2006]. Altogether, these findings highlight the
complex regulation of RIP140 expression at the
transcriptional level, which involves RIP140 in several
feed-back regulatory loops.
Biological roles of RIP140
The physiological importance of RIP140 was evaluated
using mice devoid of the RIP140 gene (RIPKO).These
RIP140-null mice were generated by replacing almost
the entire coding region by a β-galactosidase expressing
cassette [White et al., 2000]. RIPKO mice are viable but
exhibited several interesting phenotypes. First, the female
RIPKO mice are infertile because of defective ovulation
(mature follicles fail to release oocytes although granulosa
cells undergo luteinization and oocytes could be fertilized
in vitro). Embryo transfer experiments indicated that
RIP140 was not essential for the preparation of the uterus
for implantation. Moreover, ovarian transplantation
experiments showed that ovaries are the essential site
of RIP140 action in female fertility [Leonardsson et al.,
2002].
The second interesting phenotype is at the level of the
white adipose tissue. RIPKO mice have a reduced body
weight and body fat content.They exhibit a resistance to
high-fat diet-induced obesity and increased oxygen
consumption [Leonardsson et al., 2004]. Data indicate
that RIP140 controls the balance between energy storage
and expenditure through the regulation of specific genes
involved in energy metabolism [Christian et al., 2005].
Adipocytes isolated from RIPKO mice showed elevated
expression of genes such as the uncoupling protein 1
(ucp1) or the carnitine palmitoyltransferase 1b (CPT1b)
which are normally directly repressed by RIP140 at the
transcriptional level [Christian et al., 2005]. Along with
these data, the RIPKO adipocytes exhibited higher levels
of total fatty acid oxidation than those of wild-type cells.
More recently, it has been shown that RIPKO animals
also exhibit a higher glucose tolerance and insulin
responsiveness upon high-fat feeding [Powelka et al.,
2006]. Indeed, RIP140 appears to negatively regulate
cellular respiration, citric acid cycling, glycolysis and
hexose uptake through silencing of genes involved in
these metabolic pathways. RIP140 appears therefore to
act as a broad negative regulator of multiple metabolic
pathways in adipocytes and might therefore be considered
as a putative therapeutic target for metabolic syndromes.
At the cellular level, the role of RIP140 has also been
evaluated by a knock-down approach. Using siRNA to
silence RIP140 expression, it has been suggested that
the effects of estrogen on cell proliferation were repressed
by RIP140 [White et al., 2005]. Moreover, RIP140 also
appeared important for the antiestrogenic effect of retinoic
acid on breast cancer cell proliferation.
Alteration of RIP140 expression in
human pathology
Single nucleotide polymorphism (SNP)
Several DNA variants have been identified within the
coding sequence of RIP140, most of them introducing
amino acid changes (Figure 1) [Caballero et al., 2005].
Specific combinations of amino acid variations were found
with a higher incidence in patients presenting
endometriosis, as compared with the control population.
Moreover, the R448G SNP appeared associated with
endometriosis in a case-control study comprising 200
samples [Caballero et al., 2005].The same laboratory
reported multilocus analyses of SNP within five genes
including RIP140 in two pathologies dealing with estrogen
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infertility [Galan et al., 2005]). Interestingly, a digenic
association involving SNPs in the RIP140 and ERβ genes
appeared related to the osteoporosis status.These data
need to be confirmed by other studies, but suggest a
potential role of RIP140 in bone pathogenesis.
Deregulated expression
Surprisingly, very few studies have analyzed the
expression of RIP140 expression in human diseases.
Two studies have quantified the accumulation of the
mRNA in breast cancers, but on a very limited number
of samples [Chan et al., 1999; Rey et al., 2000]. No
significant differences in the level of RIP140 mRNA were
observed in tamoxifen-resistant breast tumors samples,
as compared to tamoxifen-treated or untreated tumors
[Chan et al., 1999].
As expected due to its location on chromosome 21, the
expression of the RIP140 protein appeared increased in
the hippocampus of a patient with Down’s syndrome
[Gardiner, 2006].The gene was also found to be
significantly up-regulated in acute myeloid leukemia with
complex karyotypes and abnormal chromosome 21
[Baldus et al., 2004].
Conclusions
RIP140 is an unconventional transcriptional cofactor
which acts mainly as a negative regulator of
hormone-dependent nuclear receptor activity, thus
counterbalancing the effect of coactivators. Several
inhibitory modules are involved in the transrepressive
function of RIP140 which appears to be finely tuned by
post-translational modifications.The expression of the
gene is under complex regulation and implicates several
regulatory loops and cross-talk interactions.
However, although a significant amount of work has been
performed on RIP140 to decipher its mechanism of action
and to define its biological relevance, several questions
still remain unanswered. Does RIP140 act as a repressor
for transcription factors other than nuclear receptors?
What is the physiological importance of the transcriptional
and post-transcriptional regulation of RIP140 expression?
What is the exact interplay between the different
post-translational modifications and their roles in
controlling the biological activity of RIP140? What is the
relevance of this coregulator in hormone-dependent
carcinogenesis and other pathologies?
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